Jordan received the first shipment of 144,000 doses of the AstraZeneca/SK Bioscience COVID-19 vaccine from COVAX Facility facility at Queen Alia International Airport.

“We now see the results of partnership with the COVAX Facility. This supply is very timely to support our efforts to accelerate the COVID-19 national immunization campaign. We will continue offering the COVID-19 vaccines to the most vulnerable populations.” said Nathir Obeidat, Minister of Health.

EU Ambassador to Jordan Maria Hadjitheodosiou highlighted that ” The European Union has been leading international efforts to ensure vaccine equity and low- and middle-income countriesdelivery to low and middle income countries. Through Team Europe’s €2.2 billion contribution to the COVAX Facility, we aim to ensure that all our partners have access to safe and effective vaccines. We can only add our voice to that of the Jordanian government in encouraging people to register on the Ministry of Health’s platform to receive the vaccine, as they are steadily becoming available.“

COVAX is a global facility representing partnership between the World Health Organization (WHO), Global Alliance for Vaccines and Immunization (GAVI) and the Coalition for Epidemic Preparedness Innovations (CEPI) working on the equitable distribution of COVID-19 vaccines. It includes 190 countries with population of more than 7 billion people and ensures fair and equal access to COVID-19 vaccines supplied through UNICEF. The European Union (EU), WHO and UNICEF are supporting the Government of Jordan’s national vaccination campaign.

A total of €8 million has been made available by the EU to support the Ministry of Health’s purchase of COVID-19 vaccines through COVAX Facility facility through its “Jordan Health Programme for Syrian Refugees and Vulnerable Jordanians,” implemented by the WHO and funded by the Madad Fund. A second shipment of COVID-19 vaccines from the COVAX Facility facility is expected to arrive in Jordan in April.

Read more

Press release